Symmetry Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$223K	Buy	288 +7	+2%	+$5.36K	0.01%	183
2025 Q4	$217K	Buy	+281	New	+$191K	0.01%	185
2024 Q3	–	Sell	-779	Closed	-$819K	–	415
2024 Q2	$819K	Hold	779	–	–	0.04%	200
2024 Q1	$750K	Sell	779 -94	-11%	-$89.4K	0.06%	225
2023 Q4	$770K	Sell	873 -310	-26%	-$255K	0.04%	207
2023 Q3	$974K	Sell	1,183 -163	-12%	-$128K	0.05%	185
2023 Q2	$967K	Sell	1,346 -403	-23%	-$311K	0.05%	195
2023 Q1	$1.44M	Buy	1,749 +164	+10%	+$124K	0.08%	136
2022 Q4	$1.14M	Sell	1,585 -79	-5%	-$58.3K	0.07%	161
2022 Q3	$1.15M	Buy	1,664 +134	+9%	+$84.3K	0.08%	148
2022 Q2	$904K	Sell	1,530 -1,002	-40%	-$651K	0.06%	189
2022 Q1	$1.77M	Buy	2,532 +1,637	+183%	+$1.04M	0.11%	103
2021 Q4	$565K	Hold	895	–	–	0.04%	354
2021 Q3	$493K	Buy	895 +80	+10%	+$49.7K	0.03%	411
2021 Q2	$455K	Buy	815 +222	+37%	+$112K	0.03%	461
2021 Q1	$281K	Sell	593 -539	-48%	-$262K	0.02%	572
2020 Q4	$547K	Sell	1,132 -912	-45%	-$492K	0.04%	347
2020 Q3	$1.14M	Buy	2,044 +898	+78%	+$544K	0.1%	137
2020 Q2	$715K	Buy	+1,146	New	+$650K	0.09%	95